Do analysts recommend NNNN or TMCI?

Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 5.94%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than Anbio Biotechnology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anbio Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Treace Medical Concepts 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.86

Which has higher earnings and valuation, NNNN or TMCI?

Anbio Biotechnology has higher earnings, but lower revenue than Treace Medical Concepts. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Anbio Biotechnology $8.65M 109.79 $6.40M N/A N/A Treace Medical Concepts $212.69M 1.49 -$59M -$0.93 N/A

Does the media refer more to IRMD or TMCI?

In the previous week, iRadimed had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for iRadimed and 1 mentions for Treace Medical Concepts. iRadimed's average media sentiment score of 1.69 beat Treace Medical Concepts' score of 1.34 indicating that iRadimed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRadimed 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CBLL or TMCI?

In the previous week, CeriBell had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for CeriBell and 1 mentions for Treace Medical Concepts. CeriBell's average media sentiment score of 1.39 beat Treace Medical Concepts' score of 1.34 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BBNX or TMCI?

In the previous week, Beta Bionics had 10 more articles in the media than Treace Medical Concepts. MarketBeat recorded 11 mentions for Beta Bionics and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat Beta Bionics' score of 0.76 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer INMD or TMCI?

In the previous week, InMode had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for InMode and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat InMode's score of 0.34 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Treace Medical Concepts (TMCI) Competitors

$4.88 +0.18 (+3.83%)

As of 09/3/2026 04:00 PM Eastern

Compare

TMCI vs. NNNN, IRMD, CBLL, BBNX, and INMD

Should you buy Treace Medical Concepts stock or one of its competitors? Treace Medical Concepts's main competitors and comparable companies include Anbio Biotechnology (NNNN), iRadimed (IRMD), CeriBell (CBLL), Beta Bionics (BBNX), and InMode (INMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Treace Medical Concepts compare to Anbio Biotechnology?

Anbio Biotechnology (NASDAQ:NNNN) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

In the previous week, Treace Medical Concepts had 1 more articles in the media than Anbio Biotechnology. MarketBeat recorded 1 mentions for Treace Medical Concepts and 0 mentions for Anbio Biotechnology. Treace Medical Concepts' average media sentiment score of 1.34 beat Anbio Biotechnology's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Overall Sentiment
Anbio Biotechnology	Neutral
Treace Medical Concepts	Positive

Anbio Biotechnology has higher earnings, but lower revenue than Treace Medical Concepts.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anbio Biotechnology	$8.65M	109.79	$6.40M	N/A	N/A
Treace Medical Concepts	$212.69M	1.49	-$59M	-$0.93	N/A

Anbio Biotechnology has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -28.99%. Anbio Biotechnology's return on equity of 0.00% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anbio Biotechnology	N/A	N/A	N/A
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

84.1% of Treace Medical Concepts shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Anbio Biotechnology has a beta of 5.17, indicating that its share price is 417% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 5.94%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than Anbio Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anbio Biotechnology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Treace Medical Concepts beats Anbio Biotechnology on 8 of the 14 factors compared between the two stocks.

How does Treace Medical Concepts compare to iRadimed?

iRadimed (NASDAQ:IRMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

iRadimed currently has a consensus price target of $120.00, suggesting a potential upside of 38.58%. Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 5.94%. Given iRadimed's stronger consensus rating and higher probable upside, equities analysts clearly believe iRadimed is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRadimed	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, iRadimed had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for iRadimed and 1 mentions for Treace Medical Concepts. iRadimed's average media sentiment score of 1.69 beat Treace Medical Concepts' score of 1.34 indicating that iRadimed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRadimed	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRadimed has higher earnings, but lower revenue than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRadimed	$83.81M	13.21	$22.48M	$1.79	48.37
Treace Medical Concepts	$212.69M	1.49	-$59M	-$0.93	N/A

iRadimed has a net margin of 26.70% compared to Treace Medical Concepts' net margin of -28.99%. iRadimed's return on equity of 23.45% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRadimed	26.70%	23.45%	20.36%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

92.3% of iRadimed shares are owned by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are owned by institutional investors. 34.6% of iRadimed shares are owned by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

iRadimed has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market.

Summary

iRadimed beats Treace Medical Concepts on 15 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to CeriBell?

CeriBell (NASDAQ:CBLL) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

CeriBell currently has a consensus target price of $24.40, indicating a potential downside of 0.69%. Treace Medical Concepts has a consensus target price of $5.17, indicating a potential upside of 5.94%. Given Treace Medical Concepts' higher probable upside, analysts clearly believe Treace Medical Concepts is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, CeriBell had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for CeriBell and 1 mentions for Treace Medical Concepts. CeriBell's average media sentiment score of 1.39 beat Treace Medical Concepts' score of 1.34 indicating that CeriBell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has a net margin of -28.99% compared to CeriBell's net margin of -64.73%. CeriBell's return on equity of -44.85% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-64.73%	-44.85%	-35.69%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

CeriBell has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

CeriBell has higher earnings, but lower revenue than Treace Medical Concepts. CeriBell is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	10.59	-$53.41M	-$1.76	N/A
Treace Medical Concepts	$212.69M	1.49	-$59M	-$0.93	N/A

84.1% of Treace Medical Concepts shares are owned by institutional investors. 17.7% of CeriBell shares are owned by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Treace Medical Concepts beats CeriBell on 9 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

84.1% of Treace Medical Concepts shares are held by institutional investors. 5.3% of Beta Bionics shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Beta Bionics had 10 more articles in the media than Treace Medical Concepts. MarketBeat recorded 11 mentions for Beta Bionics and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat Beta Bionics' score of 0.76 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beta Bionics	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has higher revenue and earnings than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	8.94	-$73.20M	-$1.65	N/A
Treace Medical Concepts	$212.69M	1.49	-$59M	-$0.93	N/A

Beta Bionics currently has a consensus price target of $20.10, suggesting a potential upside of 0.90%. Treace Medical Concepts has a consensus price target of $5.17, suggesting a potential upside of 5.94%. Given Treace Medical Concepts' higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Beta Bionics has a beta of 3.37, meaning that its stock price is 237% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

Treace Medical Concepts has a net margin of -28.99% compared to Beta Bionics' net margin of -61.31%. Beta Bionics' return on equity of -26.30% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-61.31%	-26.30%	-23.25%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

Summary

Treace Medical Concepts beats Beta Bionics on 9 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to InMode?

InMode (NASDAQ:INMD) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

68.0% of InMode shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 6.9% of InMode shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

InMode presently has a consensus target price of $16.00, suggesting a potential upside of 7.82%. Treace Medical Concepts has a consensus target price of $5.17, suggesting a potential upside of 5.94%. Given InMode's stronger consensus rating and higher possible upside, equities analysts clearly believe InMode is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, InMode had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for InMode and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.34 beat InMode's score of 0.34 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

InMode has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market.

InMode has a net margin of 20.69% compared to Treace Medical Concepts' net margin of -28.99%. InMode's return on equity of 11.99% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
Treace Medical Concepts	-28.99%	-71.37%	-30.49%

InMode has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.30	$93.83M	$1.23	12.07
Treace Medical Concepts	$212.69M	1.49	-$59M	-$0.93	N/A

Summary

InMode beats Treace Medical Concepts on 12 of the 15 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$305.66M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	-5.25	25.93	273.28	25.38
Price / Sales	1.49	73.29	613.48	92.60
Price / Cash	N/A	33.14	77.82	52.26
Price / Book	4.69	6.04	12.89	6.14
Net Income	-$59M	$150.03M	$3.47B	$349.01M
7 Day Performance	4.95%	-1.30%	0.61%	-0.27%
1 Month Performance	2.95%	1.29%	5.73%	0.68%
1 Year Performance	-31.94%	9.89%	25.37%	14.84%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	2.8818 of 5 stars	$4.88 +3.8%	$5.17 +5.9%	-32.7%	$305.66M	$212.69M	N/A	250	Positive News Gap Up
NNNN Anbio Biotechnology	0.5454 of 5 stars	$7.83 -0.9%	N/A	N/A	$1.14B	$8.65M	N/A	27
IRMD iRadimed	2.5728 of 5 stars	$87.87 +0.8%	$120.00 +36.6%	+22.6%	$1.11B	$83.81M	49.09	110	Positive News
CBLL CeriBell	1.4268 of 5 stars	$23.95 +0.0%	$22.40 -6.5%	+111.6%	$918.77M	$89.06M	N/A	N/A	Positive News Analyst Forecast
BBNX Beta Bionics	1.3345 of 5 stars	$19.34 -2.0%	$20.10 +3.9%	+1.2%	$887.65M	$100.25M	N/A	294	News Coverage Insider Trade Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. NNNN, IRMD, CBLL, BBNX, and INMD

How does Treace Medical Concepts compare to Anbio Biotechnology?

Summary

How does Treace Medical Concepts compare to iRadimed?

Summary

How does Treace Medical Concepts compare to CeriBell?

Summary

How does Treace Medical Concepts compare to Beta Bionics?

Summary

How does Treace Medical Concepts compare to InMode?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. NNNN, IRMD, CBLL, BBNX, and INMD

How does Treace Medical Concepts compare to Anbio Biotechnology?

Does the media prefer NNNN or TMCI?

Which has higher earnings and valuation, NNNN or TMCI?

Is NNNN or TMCI more profitable?

Do institutionals and insiders have more ownership in NNNN or TMCI?

Which has more risk and volatility, NNNN or TMCI?

Do analysts recommend NNNN or TMCI?

Summary

How does Treace Medical Concepts compare to iRadimed?

Do analysts prefer IRMD or TMCI?

Does the media refer more to IRMD or TMCI?

Which has higher valuation & earnings, IRMD or TMCI?

Is IRMD or TMCI more profitable?

Do institutionals & insiders have more ownership in IRMD or TMCI?

Which has more volatility & risk, IRMD or TMCI?

Summary

How does Treace Medical Concepts compare to CeriBell?

Do analysts rate CBLL or TMCI?

Does the media refer more to CBLL or TMCI?

Is CBLL or TMCI more profitable?

Which has more volatility and risk, CBLL or TMCI?

Which has stronger valuation & earnings, CBLL or TMCI?

Do institutionals and insiders hold more shares of CBLL or TMCI?

Summary

How does Treace Medical Concepts compare to Beta Bionics?

Do institutionals and insiders have more ownership in BBNX or TMCI?

Does the media prefer BBNX or TMCI?

Which has preferable earnings and valuation, BBNX or TMCI?

Do analysts rate BBNX or TMCI?

Which has more volatility and risk, BBNX or TMCI?

Is BBNX or TMCI more profitable?

Summary

How does Treace Medical Concepts compare to InMode?

Do institutionals & insiders have more ownership in INMD or TMCI?

Do analysts rate INMD or TMCI?

Does the media prefer INMD or TMCI?

Which has more risk & volatility, INMD or TMCI?

Is INMD or TMCI more profitable?

Which has stronger valuation and earnings, INMD or TMCI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools